Chimeric antigen receptor T cell therapy in multiple myeloma: promise and challenges
Author:
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Link
https://www.nature.com/articles/s41409-020-01023-w.pdf
Reference67 articles.
1. Dhakal B, Girnius S, Hari P. Recent advances in understanding multiple myeloma. F1000Res. 2016;5. https://doi.org/10.12688/f1000research.8777.1.
2. Kumar SK, Rajkumar V, Kyle RA, Van Duin M, Sonneveld P, Mateos MV, et al. Multiple myeloma. Nat Rev Dis Primers. 2017;3:17046. https://doi.org/10.1038/nrdp.2017.46.
3. Neri P, Bahlis NJ, Lonial S. New strategies in multiple myeloma: immunotherapy as a novel approach to treat patients with multiple myeloma. Clin Cancer Res. 2016;22:5959–65. https://doi.org/10.1158/1078-0432.CCR-16-0184.
4. Lonial S, Dimopoulos M, Palumbo A, White D, Grosciki S, Spicka I, et al. Elotuzumab therapy for relapsed or refractory multiple myeloma. N. Engl J Med. 2015;373:621–31. https://doi.org/10.1056/NEJMoa1505654.
5. Dimopoulos MA, Oriol A, Nahi H, San-Miguel J, Bahlis N, Usmani S, et al. Daratumumab, lenalidomide, and dexamethasone for multiple myeloma. N. Engl J Med. 2016;375:1319–31. https://doi.org/10.1056/NEJMoa1607751.
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma;Journal for ImmunoTherapy of Cancer;2024-01
2. Nicotinamide-Expanded Allogeneic Natural Killer Cells with CD38 Deletion, Expressing an Enhanced CD38 Chimeric Antigen Receptor, Target Multiple Myeloma Cells;International Journal of Molecular Sciences;2023-12-07
3. Alliance between titans: combination strategies of CAR-T cell therapy and oncolytic virus for the treatment of hematological malignancies;Annals of Hematology;2023-10-18
4. A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma;Journal of Translational Internal Medicine;2023-09-01
5. Combination of immune checkpoint blockade and targeted gene regulation of angiogenesis for facilitating antitumor immunotherapy;Frontiers in Bioengineering and Biotechnology;2023-03-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3